Thursday, May 7, 2026

APEC 2025: What to Expect from the Trump-Xi Showdown in South Korea?

APEC summit in Gyeongju sees key leaders, including Trump and Xi, addressing U.S.-China relations and North Korea's role in diplomacy.

North Korea Asks South to Reduce Border Warnings; Request Rejected by Seoul

North Korea requested South Korea to reduce military broadcasts, but the latter rejected it to maintain readiness amid rising tensions.

IOC Confirms North Korea Didn’t Get Samsung Galaxy Phones

The International Olympic Committee (IOC) officially stated yesterday that the NOC of DPRK did not receive Samsung smartphones.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube brand will sponsor Coachella, showcasing beauty tech and products to enhance global brand awareness.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

KIMES 2026: How South Korea’s Medical Device Industry is Poised for Global Expansion

KIMES 2026 showcases Korea's medical device sector, highlighting digital growth and global expansion opportunities for domestic companies.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

How This New Blood Test Using Nanotechnology Could Change Brain Disease Monitoring Forever

South Korean researchers developed a blood test to track brain disease progression, potentially replacing imaging scans for monitoring.

How the New MOU Between Financial and Medical Institutions Will Transform Care for the Underprivileged

A new support system links community finance with public healthcare to aid financially vulnerable populations in accessing medical assistance.

Unlocking the Future of Healthcare: How Dong-A ST and Dou are Revolutionizing AI Solutions in 2026

Dong-A ST partners with Dou for AI solutions to enhance digital healthcare and improve patient experiences in hospitals nationwide.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.